Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Shares Issued (2018 - 2023)

Precision Biosciences (DTIL) has disclosed Shares Issued for 6 consecutive years, with $1000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Shares Issued fell 80.0% to $1000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $31000.0, a 92.09% decrease, with the full-year FY2023 number at $31000.0, down 92.09% from a year prior.
  • Shares Issued was $1000.0 for Q4 2023 at Precision Biosciences, down from $30000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $135.1 million in Q2 2019 to a low of -$134.7 million in Q3 2019.
  • A 5-year average of $1.5 million and a median of $205000.0 in 2020 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 217767.74% in 2019; the steepest drop was 499155.56% in 2019.
  • Precision Biosciences' Shares Issued stood at $821000.0 in 2019, then plummeted by 75.88% to $198000.0 in 2020, then surged by 3610.61% to $7.3 million in 2021, then tumbled by 99.93% to $5000.0 in 2022, then plummeted by 80.0% to $1000.0 in 2023.
  • Per Business Quant, the three most recent readings for DTIL's Shares Issued are $1000.0 (Q4 2023), $30000.0 (Q1 2023), and $5000.0 (Q4 2022).